Protection of protease inhibitor of Momordica charantia on activity of hypoglycemic peptides from M. charantia

Chinese Traditional and Herbal Drugs

Volumn 40, Issue 8, 2009, Pages 1259-1262

  Fu, Zhong Ping ^a   Liu, Hong Yu ^a   Lu, Lan ^a   Chen, Zi Jun ^a   Zhou, Ji Yan ^a   Wang, Fu Jun ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Diabetes; Hypoglycemic peptide; Momordica charantia L.; Protease inhibitor

Indexed keywords

ALLOXAN; GLUCOSE; HYPOGLYCEMIC PEPTIDE; MOMORDICA CHARANTIA EXTRACT; PEPTIDE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; MOMORDICA CHARANTIA; MOUSE; NONHUMAN; PROTEIN DETERMINATION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 70349686823     PISSN: 02532670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Khanna P. Hypoglycemic activity of polypeptide-p from a plant source [J]. J Nat Prod, 1981, 44(6): 648-655.
2. Nobuaki H. Trypsin and elastase inhibitors from bitter gourd (Momordica charantia Linn.) seeds: Purification, amino acid sequences, and inhibitory activities of four new inhibitors [J]. J Biochem, 1995, 117: 432-437.